CollPlant Biotechnologies Ltd. (CLGN) DCF Valuation

CollPlant Biotechnologies Ltd. (CLGN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

CollPlant Biotechnologies Ltd. (CLGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of CollPlant Biotechnologies Ltd.? Our (CLGN) DCF Calculator integrates real-world data with extensive customization options, enabling you to refine your forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .6 1.7 4.2 .1 3.0 4.5 6.7 10.1 15.2 22.9
Revenue Growth, % 0 164.75 154.86 -98.09 3565.22 50.48 50.48 50.48 50.48 50.48
EBITDA -1.9 -1.3 .2 -4.3 -1.7 -3.0 -4.5 -6.8 -10.2 -15.3
EBITDA, % -305.95 -80.48 5.36 -5358.19 -58.49 -66.72 -66.72 -66.72 -66.72 -66.72
Depreciation .1 .2 .2 .3 .3 1.3 2.0 3.0 4.5 6.8
Depreciation, % 23.25 10.75 4.94 359.87 10.06 29.8 29.8 29.8 29.8 29.8
EBIT -2.1 -1.5 .0 -4.6 -2.0 -3.2 -4.8 -7.3 -11.0 -16.5
EBIT, % -329.21 -91.23 0.41557 -5718.06 -68.55 -71.87 -71.87 -71.87 -71.87 -71.87
Total Cash 1.0 .9 11.7 8.0 7.2 4.1 6.1 9.2 13.9 20.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .2 .1 .0 .1
Account Receivables, % 3.41 13.52 1.73 3.01 3.59
Inventories .2 .3 .3 .4 .2 1.5 2.3 3.5 5.3 7.9
Inventories, % 38.31 20.56 6.91 478.26 6.52 34.46 34.46 34.46 34.46 34.46
Accounts Payable .2 .2 .3 .3 .3 1.5 2.2 3.3 5.0 7.5
Accounts Payable, % 35.94 13 6.61 378.93 8.94 32.9 32.9 32.9 32.9 32.9
Capital Expenditure -.4 -.1 -.4 -.4 -.3 -1.7 -2.6 -3.9 -5.8 -8.8
Capital Expenditure, % -64.32 -8.46 -10.16 -440.13 -8.71 -38.33 -38.33 -38.33 -38.33 -38.33
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.7 -1.5 .0 -4.6 -2.0 -3.2 -4.8 -7.3 -10.9 -16.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.0 -1.8 .1 -4.7 -1.9 -3.9 -5.6 -8.4 -12.6 -18.9
WACC, % 6.68 6.68 6.68 6.68 6.68 6.68 6.68 6.68 6.68 6.68
PV UFCF
SUM PV UFCF -38.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -19
Terminal Value -412
Present Terminal Value -298
Enterprise Value -337
Net Debt -6
Equity Value -331
Diluted Shares Outstanding, MM 11
Equity Value Per Share -29.03

What You Will Get

  • Real CollPlant Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on CollPlant’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Comprehensive Data: CollPlant's historical financial records and pre-filled projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe CollPlant's intrinsic value recalibrating instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered CollPlant Biotechnologies Ltd. (CLGN) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for CollPlant Biotechnologies Ltd. (CLGN)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for CollPlant Biotechnologies Ltd. (CLGN)?

  • Accuracy: Utilizes real CollPlant financials for reliable data.
  • Flexibility: Allows users to easily adjust and test different inputs.
  • Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected by CFOs.
  • User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Biotech Investors: Develop comprehensive and accurate valuation models for portfolio assessment in the biotech sector.
  • Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for CollPlant Biotechnologies Ltd. (CLGN) to clients.
  • Students and Educators: Utilize real-time data for practicing and teaching financial modeling in biotechnology.
  • Healthcare Enthusiasts: Gain insights into how biotech companies like CollPlant are valued in the marketplace.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled CollPlant Biotechnologies Ltd. (CLGN) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for CollPlant Biotechnologies Ltd. (CLGN).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.